CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+12.98%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.24B
AUM Growth
+$1.24B
Cap. Flow
+$168M
Cap. Flow %
13.47%
Top 10 Hldgs %
48.36%
Holding
62
New
13
Increased
6
Reduced
5
Closed
6

Top Buys

1
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$43.1M
2
AUTL
Autolus Therapeutics
AUTL
$40.9M
3
TCDA
Tricida, Inc. Common Stock
TCDA
$27.9M
4
KZR icon
Kezar Life Sciences
KZR
$27.2M
5
SPPI
Spectrum Pharmaceuticals Inc
SPPI
$25.2M

Top Sells

1
NKTR icon
Nektar Therapeutics
NKTR
$51.9M
2
AVXS
AveXis, Inc. Common Stock
AVXS
$23.7M
3
VYNE icon
VYNE Therapeutics
VYNE
$12.7M
4
CLSD icon
Clearside Biomedical
CLSD
$7.28M
5
KDMN
Kadmon Holdings, Inc.
KDMN
$7.01M

Sector Composition

1 Healthcare 95.91%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNS
51
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.38M 0.25% 478,111 – –
SRRK icon
52
Scholar Rock
SRRK
$3.14B
$3.28M 0.24% +210,078 New +$3.28M
MGTX icon
53
MeiraGTx Holdings
MGTX
$587M
$2.73M 0.2% +238,580 New +$2.73M
PTGX icon
54
Protagonist Therapeutics
PTGX
$3.67B
$2.57M 0.19% 382,139 – –
ONSIW
55
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$20K ﹤0.01% 416,666 – –
CLRBW
56
DELISTED
Cellectar Biosciences, Inc.
CLRBW
$10K ﹤0.01% 52,999 – –
EOLS icon
57
Evolus
EOLS
$494M
– – -342,400 Closed -$3.09M
VYNE icon
58
VYNE Therapeutics
VYNE
$8.16M
– – -336,714 Closed -$12.7M
JNCE
59
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– – -82,988 Closed -$1.86M
KDMN
60
DELISTED
Kadmon Holdings, Inc.
KDMN
– – -1,648,432 Closed -$7.01M
ONSIZ
61
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
– – -416,666 Closed -$18K
AVXS
62
DELISTED
AveXis, Inc. Common Stock
AVXS
– – -192,094 Closed -$23.7M
1 2
3